Candriam Luxembourg S.C.A. boosted its stake in Cooper Companies Inc (NYSE:COO) by 83.6% in the 4th quarter, Holdings Channel reports. The firm owned 41,848 shares of the medical device company’s stock after purchasing an additional 19,060 shares during the period. Candriam Luxembourg S.C.A.’s holdings in Cooper Companies were worth $9,118,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Advisory Services Network LLC increased its holdings in Cooper Companies by 30.6% in the 2nd quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock valued at $109,000 after purchasing an additional 107 shares during the last quarter. Canada Pension Plan Investment Board acquired a new position in shares of Cooper Companies in the third quarter worth $163,000. Ballentine Partners LLC acquired a new position in shares of Cooper Companies in the third quarter worth $223,000. CAPROCK Group Inc. acquired a new position in shares of Cooper Companies in the fourth quarter worth $222,000. Finally, FNY Managed Accounts LLC acquired a new position in shares of Cooper Companies in the fourth quarter worth $217,000. Hedge funds and other institutional investors own 96.27% of the company’s stock.

In related news, Director Allan E. Rubenstein sold 500 shares of the business’s stock in a transaction on Wednesday, December 27th. The shares were sold at an average price of $222.00, for a total transaction of $111,000.00. Following the completion of the transaction, the director now owns 6,590 shares in the company, valued at $1,462,980. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Allan E. Rubenstein sold 6,450 shares of the business’s stock in a transaction on Friday, January 12th. The stock was sold at an average price of $228.79, for a total transaction of $1,475,695.50. Following the transaction, the director now owns 8,628 shares of the company’s stock, valued at approximately $1,974,000.12. The disclosure for this sale can be found here. In the last quarter, insiders have sold 54,385 shares of company stock valued at $12,289,463. Insiders own 1.60% of the company’s stock.

Several equities analysts have commented on the stock. Zacks Investment Research downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, November 1st. Oppenheimer set a $250.00 price target on shares of Cooper Companies and gave the stock a “hold” rating in a research note on Friday, December 8th. Stifel Nicolaus restated a “buy” rating and issued a $265.00 price target (down previously from $275.00) on shares of Cooper Companies in a research note on Friday, December 8th. KeyCorp restated a “hold” rating on shares of Cooper Companies in a research note on Friday, October 20th. Finally, Raymond James Financial restated a “buy” rating and issued a $265.00 price target on shares of Cooper Companies in a research note on Monday, December 4th. Eight investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $259.70.

Cooper Companies Inc (NYSE COO) opened at $225.82 on Wednesday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.26 and a current ratio of 2.41. The company has a market cap of $11,116.09, a price-to-earnings ratio of 23.33, a P/E/G ratio of 1.83 and a beta of 0.57. Cooper Companies Inc has a 12 month low of $189.41 and a 12 month high of $256.39.

Cooper Companies (NYSE:COO) last issued its earnings results on Thursday, December 7th. The medical device company reported $2.65 EPS for the quarter, topping analysts’ consensus estimates of $2.64 by $0.01. The firm had revenue of $561.50 million during the quarter, compared to the consensus estimate of $558.86 million. Cooper Companies had a net margin of 17.43% and a return on equity of 16.02%. The company’s revenue was up 8.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.28 earnings per share. analysts expect that Cooper Companies Inc will post 11.55 EPS for the current year.

The company also recently announced a semiannual dividend, which was paid on Friday, February 9th. Investors of record on Tuesday, January 23rd were paid a dividend of $0.03 per share. The ex-dividend date of this dividend was Monday, January 22nd. This represents a dividend yield of 0.03%. Cooper Companies’s payout ratio is currently 0.80%.

WARNING: “Candriam Luxembourg S.C.A. Boosts Position in Cooper Companies Inc (COO)” was first published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this piece on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright legislation. The original version of this piece can be read at https://theolympiareport.com/2018/02/14/candriam-luxembourg-s-c-a-boosts-position-in-cooper-companies-inc-coo.html.

Cooper Companies Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.